Opus Genetics (IRD) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,003.53% |
| Dec 31, 2025 | 128.26% |
| Sep 30, 2025 | -82.60% |
| Jun 30, 2025 | -57.00% |
| Mar 31, 2025 | -88.99% |
| Dec 31, 2024 | -86.53% |
| Sep 30, 2024 | -31.78% |
| Jun 30, 2024 | 7.78% |
| Mar 31, 2024 | 11.65% |
| Dec 31, 2023 | 7.93% |
| Sep 30, 2023 | 323.36% |
| Jun 30, 2023 | 158.34% |
| Mar 31, 2023 | 138.83% |
| Dec 31, 2022 | 108.08% |
| Sep 30, 2022 | -42.25% |
| Jun 30, 2022 | -35.29% |
| Mar 31, 2022 | 75.96% |
| Dec 31, 2021 | 265.01% |
| Sep 30, 2021 | 318.55% |
| Jun 30, 2021 | 356.93% |
| Mar 31, 2021 | 216.01% |
| Dec 31, 2020 | -78.13% |
| Sep 30, 2020 | -180.05% |
| Jun 30, 2020 | -164.43% |
| Mar 31, 2020 | -153.08% |
| Dec 31, 2019 | -344.97% |
| Sep 30, 2019 | 83.33% |
| Jun 30, 2019 | 19.26% |
| Mar 31, 2019 | 6.48% |
| Dec 31, 2018 | -110.13% |
| Sep 30, 2018 | -57.60% |
| Jun 30, 2018 | -28.16% |
| Mar 31, 2018 | 1,225.32% |
| Dec 31, 2017 | -1.70% |
| Sep 30, 2017 | -12.29% |
| Jun 30, 2017 | 0.55% |
| Mar 31, 2017 | -93.44% |
| Dec 31, 2016 | -9.15% |
| Sep 30, 2016 | -2.64% |
| Jun 30, 2016 | -26.20% |
| Mar 31, 2016 | -26.39% |
| Dec 31, 2015 | -29.36% |
| Sep 30, 2015 | -38.08% |
| Jun 30, 2015 | -29.30% |
| Mar 31, 2015 | -16.60% |
| Dec 31, 2014 | 110.53% |
| Sep 30, 2014 | 190.29% |
| Jun 30, 2014 | 450.85% |
| Mar 31, 2014 | 234.68% |
| Dec 31, 2013 | 32.43% |
| Sep 30, 2013 | 107.95% |
| Jun 30, 2013 | -28.22% |
| Mar 31, 2013 | -3.25% |
| Dec 31, 2012 | -10.95% |
| Sep 30, 2012 | -53.43% |
| Jun 30, 2012 | -33.21% |
| Dec 31, 2011 | 2.99% |